The MarketWatch News Department was not involved in the creation of this content. ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney ...
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results